Earlier this week, PatientsLikeMe announced a five-year collaboration with Genentech. Our goal? To bring your experience – the patient experience – to a company that wants to learn more from the people who are living with serious diseases, and to better integrate your insights into their decision-making as they develop new medicines. PatientsLikeMe Co-founder and […]
FOR IMMEDIATE RELEASE PatientsLikeMe Continues Report Series on Real-World Patient Experiences with Multiple Sclerosis Medications CAMBRIDGE, MA – November 3, 2011 – In the second report of a series on Multiple Sclerosis (MS) disease modifying therapies (DMTs), PatientsLikeMe reveals that MS patients perceive Copaxone as having comparable efficacy and tolerability profiles to the interferon therapies
Philadelphia, the city of brotherly love, provided the perfect backdrop for e-Patient Connections 2011, a two day summit about reaching and engaging both patients and their caregivers in the digital age. Right away conference organizers set the tone that the patient voice should be our focus by introducing respected e-patient bloggers and advocates, such as
What We Took Away from e-Patient Connections Read More »
Thanks everyone for a great 2010. As we kick off the New Year, PatientsLikeMe would like to take a quick look back at the road we’ve traveled together this year. We think of all these improvements as laying the groundwork for even more exciting changes to come in 2011. At the start of 2010, we
One for All: A PatientsLikeMe Year in Review (Part 1) Read More »
Today, more than 3,600 people with ALS are sharing their health data and experiences with patients like them. Recently, we announced our new genetic search engine for ALS patients, designed to help members find others like them, right down to the molecular level. With 10% of all newly diagnosed ALS patients joining PatientsLikeMe, there are
FALS Patients Like You: An Interview with Samperio Read More »
